Showing results (331-340 of 354) with videos related to

Sort By:
Pageof 36
Bioorganic & Medicinal Chemistry Letters|December 20, 2011
Novel heterocyclic DPP-4 inhibitors for the treatment of type 2 diabetesJon M Sutton, David E Clark, Stephen J Dunsdon, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|April 26, 2024
Revisiting the use of the EORTC QLQ-STO22 to assess health-related quality of life of patients with gastric cancer: incorporating updated treatment options and cross-cultural perspectivesS C Sodergren, A Hurley-Wallace, V Vassiliou, et al.
Genes & Development|April 4, 2015
miR-182 integrates apoptosis, growth, and differentiation programs in glioblastomaFotini M Kouri, Lisa A Hurley, Weston L Daniel, et al.
Medchemcomm|July 24, 2018
Targeting quinolone- and aminocoumarin-resistant bacteria with new gyramide analogs that inhibit DNA gyraseKatherine A Hurley, Thiago M A Santos, Molly R Fensterwald, et al.
Journal of Medicinal Chemistry|October 16, 2012
Discovery of potent and selective pyrazolopyrimidine janus kinase 2 inhibitorsEmily J Hanan, Anne van Abbema, Kathy Barrett, et al.
Cell Reports|June 1, 2017
Cancer-Associated IDH1 Promotes Growth and Resistance to Targeted Therapies in the Absence of MutationAndrea E Calvert, Alexandra Chalastanis, Yongfei Wu, et al.
Bioorganic & Medicinal Chemistry Letters|July 23, 2013
2-Amino-[1,2,4]triazolo[1,5-a]pyridines as JAK2 inhibitorsMichael Siu, Richard Pastor, Wendy Liu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 30, 2013
A restricted role for TYK2 catalytic activity in human cytokine responses revealed by novel TYK2-selective inhibitorsSue J Sohn, Kathy Barrett, Anne Van Abbema, et al.
The Hastings Center Report|December 9, 2022
Clarifying the Ethics and Oversight of Chimeric ResearchJosephine Johnston, Insoo Hyun, Carolyn P Neuhaus, et al.
Pageof 36